Drawing for RLS

USPTO serial 79417341

RLS

Reviewed by CopyMark Law Group

Reg. 8155669Status 700Registered
Filing date
Status date
Registration date
Mar 3, 2026
Examiner
MILMOE, MAUREEN H
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RLS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew S. Ehard

, P.O. Box 2910Minneapolis, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
005Isotopes for medical purposes; Radio-isotope markers for therapeutic or diagnostic use; Chemical products for pharmaceutical use being pharmaceutical products for the diagnosis and treatment of cancer; Pharmaceutical drugs being pharmaceutical products for the diagnosis and treatment of cancer, or skeletal, renal, cardiovascular or neurological disorders; Pharmaceutical preparations for diagnosing and suppressing tumors; Pharmaceutical preparations for the treatment of cancer; Diagnostic radiopharmaceutical preparationsACTIVE
010Diagnostic imaging apparatus for medical use; Medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disorders; Systems comprising medical apparatus and accessories for administering measured doses of pharmaceutical preparations, namely, infusion and injection devices for administering drugs; Applicators for pharmaceutical preparations, namely, medical syringes and infusion setsACTIVE
035Wholesale and retail store services featuring radiopharmaceuticals for clinical and medical use; Wholesale and retail store services featuring pharmaceuticals, medical preparations and veterinary preparations; Wholesale and retail store services featuring medical apparatus for detecting cancer, or skeletal, renal, cardiovascular or neurological disordersACTIVE
039Transportation of goods; transport and storage of chemicals; storage of pharmaceuticals.ACTIVE
040Custom manufacture of pharmaceuticals; custom manufacture of pharmaceutical preparations.ACTIVE
042Calibration of medical apparatus for detecting and treating cancer or skeletal, renal, cardiovascular or neurological disorders; Calibration of laboratory test equipment; Radiation measurement services; Scientific research and development for medical purposes in the fields of cancerous diseases or skeletal, renal, cardiovascular or neurological disordersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 3, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 24, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 24, 2026FIMPFINAL DISPOSITION PROCESSED
Aug 6, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Jul 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 19, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 3, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 3, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Jan 13, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 7, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 11, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB
Jun 28, 2025RFNTREFUSAL PROCESSED BY IB
Jun 6, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2025RFRRREFUSAL PROCESSED BY MPU
Apr 2, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2025DOCKASSIGNED TO EXAMINER
Feb 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Feb 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance